Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bonomo

Showing results (31-40 of 884) with videos related to

Pageof 89
Sort By:
Expert Review of Anti-Infective Therapy|May 26, 2011
Status report on carbapenemases: challenges and prospectsGopi Patel, Robert A Bonomo
The Lancet. Infectious Diseases|May 4, 2019
Carbapenem-resistant Enterobacteriaceae: global action requiredFederico Perez, Robert A Bonomo
Open Forum Infectious Diseases|July 16, 2016
Metallo-β-Lactamase (MBL)-Producing Enterobacteriaceae in United States ChildrenLatania K Logan, Robert A Bonomo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2006
Extended-spectrum beta-lactamases in multidrug-resistant Escherichia coli: changing the therapy for hospital-acquired and community-acquired infectionsMarion S Helfand, Robert A Bonomo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 7, 2019
Reply to Humphrey and SpaffordRobert A Bonomo, Scott R Evans
Frontiers in Bioscience : a Journal and Virtual Library|May 20, 1999
Inhibitor resistant class A beta-lactamasesR A Bonomo, L B Rice
Expert Review of Anti-Infective Therapy|October 14, 2008
Importance of antibiotic resistance and resistance mechanisms. ForewordRobert A Bonomo, Gian Maria Rossolini
Current Drug Targets. Infectious Disorders|February 7, 2003
Beta-lactamases: a survey of protein diversityMarion S Helfand, Robert A Bonomo
Mbio|June 17, 2026
Enhancing clinical utility of AI-based antimicrobial resistance models: a perspectiveRobert A Bonomo, Andrea M Hujer
Molecular Biology and Evolution|November 5, 2015
SHV-129: A Gateway to Global Suppressors in the SHV β-Lactamase Family?Marisa L Winkler, Robert A Bonomo
Pageof 89

Showing results (31-40 of 884) with videos related to

Sort By:
Pageof 89
Expert Review of Anti-Infective Therapy|May 26, 2011
Status report on carbapenemases: challenges and prospectsGopi Patel, Robert A Bonomo
The Lancet. Infectious Diseases|May 4, 2019
Carbapenem-resistant Enterobacteriaceae: global action requiredFederico Perez, Robert A Bonomo
Open Forum Infectious Diseases|July 16, 2016
Metallo-β-Lactamase (MBL)-Producing Enterobacteriaceae in United States ChildrenLatania K Logan, Robert A Bonomo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2006
Extended-spectrum beta-lactamases in multidrug-resistant Escherichia coli: changing the therapy for hospital-acquired and community-acquired infectionsMarion S Helfand, Robert A Bonomo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 7, 2019
Reply to Humphrey and SpaffordRobert A Bonomo, Scott R Evans
Frontiers in Bioscience : a Journal and Virtual Library|May 20, 1999
Inhibitor resistant class A beta-lactamasesR A Bonomo, L B Rice
Expert Review of Anti-Infective Therapy|October 14, 2008
Importance of antibiotic resistance and resistance mechanisms. ForewordRobert A Bonomo, Gian Maria Rossolini
Current Drug Targets. Infectious Disorders|February 7, 2003
Beta-lactamases: a survey of protein diversityMarion S Helfand, Robert A Bonomo
Mbio|June 17, 2026
Enhancing clinical utility of AI-based antimicrobial resistance models: a perspectiveRobert A Bonomo, Andrea M Hujer
Molecular Biology and Evolution|November 5, 2015
SHV-129: A Gateway to Global Suppressors in the SHV β-Lactamase Family?Marisa L Winkler, Robert A Bonomo
Pageof 89